Delaware Federal Judge Deems Drug Patents Valid, Infringed By ANDA
WILMINGTON, Del. — On the eve of the expiration of a 30-month stay of approval by the U.S. Food and Drug Administration of an abbreviated new drug application (ANDA) for generic...To view the full article, register now.
Already a subscriber? Click here to view full article